TTK Healthcare slumps after reverse turnaround in Q1

TTK Healthcare lost 6.43% to Rs 724 at 14:25 IST on BSE after the company reported net loss of Rs 4.47 crore in Q1 June 2017, as compared with net profit of Rs 5.59 crore in Q1 June 2016.

The Q1 result was announced during market hours today, 4 August 2017.

Meanwhile, the S&P BSE Sensex was up 68.12 points or 0.21% at 32,306. The S&P BSE Small-Cap index was up 13.80 points or 0.09% at 15,925.14.

On the BSE, 7,144 shares were traded in the counter so far, compared with average daily volumes of 885 shares in the past one quarter. The stock had hit a high of Rs 779.80 and a low of Rs 713.05 so far during the day. The stock had hit a 52-week high of Rs 1,100 on 12 September 2016. The stock had hit a 52-week low of Rs 722 on 12 July 2017.

The stock had underperformed the market over the past one month till 3 August 2017, rising 1.52% compared with 3.18% rise in the Sensex. The scrip had also underperformed the market in past one quarter, falling 1.18% as against Sensex's 7.97% rise. The scrip had also underperformed the market in past one year, sliding 16.05% as against Sensex's 16.32% rise.

The small-cap company has equity capital of Rs 7.77 crore. Face value per share is Rs 10.

TTK Healthcare's total income fell 17.81% to Rs 126.56 crore in Q1 June 2017 over Q1 June 2016.

TTK Healthcare has three strategic business units (SBUs) including pharamaceuticals divison, consumer products division and biomedical devices division. Apart from the SBUs, their satellite divisions are foods and maps.

Powered by Capital Market - Live News